Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$6.01 - $8.35 $456 - $634
-76 Reduced 0.14%
54,481 $455,000
Q3 2022

Nov 10, 2022

BUY
$5.57 - $7.46 $18,486 - $24,759
3,319 Added 6.48%
54,557 $310,000
Q2 2022

Aug 11, 2022

BUY
$5.65 - $12.19 $107,649 - $232,256
19,053 Added 59.2%
51,238 $289,000
Q1 2022

May 12, 2022

SELL
$10.93 - $14.05 $644 - $828
-59 Reduced 0.18%
32,185 $391,000
Q4 2021

Feb 10, 2022

SELL
$12.24 - $16.31 $10,489 - $13,977
-857 Reduced 2.59%
32,244 $439,000
Q3 2021

Nov 12, 2021

BUY
$14.72 - $20.66 $21,712 - $30,473
1,475 Added 4.66%
33,101 $521,000
Q2 2021

Aug 05, 2021

SELL
$17.91 - $22.41 $100,707 - $126,011
-5,623 Reduced 15.1%
31,626 $649,000
Q1 2021

May 06, 2021

SELL
$16.11 - $20.55 $24,648 - $31,441
-1,530 Reduced 3.95%
37,249 $648,000
Q4 2020

Feb 10, 2021

BUY
$12.76 - $18.33 $70,856 - $101,786
5,553 Added 16.71%
38,779 $677,000
Q3 2020

Nov 12, 2020

SELL
$9.07 - $14.82 $46,402 - $75,819
-5,116 Reduced 13.34%
33,226 $475,000
Q2 2020

Aug 13, 2020

BUY
$7.16 - $12.33 $76,075 - $131,006
10,625 Added 38.33%
38,342 $401,000
Q1 2020

May 06, 2020

BUY
$6.08 - $16.42 $21,979 - $59,358
3,615 Added 15.0%
27,717 $226,000
Q3 2019

Oct 23, 2019

BUY
$10.51 - $13.32 $20,462 - $25,934
1,947 Added 8.79%
24,102 $294,000
Q2 2019

Aug 14, 2019

BUY
$12.7 - $15.49 $23,825 - $29,059
1,876 Added 9.25%
22,155 $294,000
Q1 2019

May 01, 2019

BUY
$13.93 - $17.91 $29,057 - $37,360
2,086 Added 11.47%
20,279 $306,000
Q4 2018

Jan 31, 2019

BUY
$14.25 - $19.66 $98,538 - $135,948
6,915 Added 61.31%
18,193 $332,000
Q3 2018

Nov 07, 2018

BUY
$12.25 - $16.29 $7,987 - $10,621
652 Added 6.14%
11,278 $175,000
Q2 2018

Aug 06, 2018

BUY
$9.99 - $14.05 $106,153 - $149,295
10,626 New
10,626 $134,000

Others Institutions Holding SPNE

About SeaSpine Holdings Corp


  • Ticker SPNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,202,800
  • Description
  • SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion pr...
More about SPNE
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.